Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 139 | 2022 |
De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system A Abdel-Razik, N Mousa, R Elhelaly, A Tawfik European journal of gastroenterology & hepatology 27 (5), 585-592, 2015 | 113 | 2015 |
A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study A Abdel-Razik, N Mousa, W Shabana, M Refaey, Y ElMahdy, R Elhelaly, ... European journal of gastroenterology & hepatology 28 (1), e1-e9, 2016 | 78 | 2016 |
Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot A Abdel-Razik, N Mousa, W Shabana, M Refaey, R Elzehery, R Elhelaly, ... European journal of gastroenterology & hepatology 30 (10), 1237-1246, 2018 | 74 | 2018 |
Ascitic fluid calprotectin and serum procalcitonin as accurate diagnostic markers for spontaneous bacterial peritonitis A Abdel-Razik, N Mousa, D Elhammady, R Elhelaly, R Elzehery, S Elbaz, ... Gut and liver 10 (4), 624, 2016 | 72 | 2016 |
Helicobacter pylori and non‐alcoholic fatty liver disease: A new enigma? A Abdel‐Razik, N Mousa, W Shabana, M Refaey, R Elhelaly, R Elzehery, ... Helicobacter 23 (6), e12537, 2018 | 60 | 2018 |
Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study G Shiha, N Mousa, R Soliman, N NNH Mikhail, M Adel Elbasiony, ... Journal of viral hepatitis 27 (7), 671-679, 2020 | 52 | 2020 |
Can combined blood neutrophil to lymphocyte ratio and C-reactive protein be used for diagnosis of spontaneous bacterial peritonitis? N Mousa, T Besheer, A Abdel-Razik, M Hamed, AG Deiab, T Sheta, ... British journal of biomedical science 75 (2), 71-75, 2018 | 46 | 2018 |
The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial N Mousa, A Abdel-Razik, A Zaher, M Hamed, G Shiha, N Effat, S Elbaz, ... Therapeutic Advances in Gastroenterology 9 (5), 684-691, 2016 | 46 | 2016 |
Seroprevalence of subclinical HEV infection in asymptomatic, apparently healthy, pregnant women in Dakahlya Governorate, Egypt YZ Gad, N Mousa, M Shams, A Elewa Asian journal of transfusion science 5 (2), 136, 2011 | 42 | 2011 |
Impact of toll-like receptors 2 (TLR2) and TLR 4 gene variations on HCV susceptibility, response to treatment and development of hepatocellular carcinoma in cirrhotic HCV patients M Neamatallah, M El-Bendary, H Elalfy, T Besheer, MA El-Maksoud, ... Immunological Investigations 49 (4), 462-476, 2020 | 38 | 2020 |
Neutrophil to lymphocyte ratio as a reliable marker to predict insulin resistance and fibrosis stage in chronic hepatitis C virus infection A Abdel-Razik, N Mousa, TA Besheer, M Eissa, R Elhelaly, M Arafa, ... Acta Gastroenterol Belg 78 (4), 386-92, 2015 | 36 | 2015 |
Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis AAHA Gad YZ, Zaher AA, Mousa NH, El-desoky AE Arab Journal of Gastroenterology 12 (2), 58-61, 2011 | 35 | 2011 |
Impact of non-alcoholic fatty liver disease on pregnancy N Mousa, A Abdel-Razik, M Shams, T Sheta, S Zakaria, W Shabana, ... British Journal of Biomedical Science 75 (4), 197-199, 2018 | 32 | 2018 |
Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study A Abdel-Razik, N Mousa, R Elhelaly, R Elzehery, AS Hasan, ... Frontiers in medicine 7, 96, 2020 | 26 | 2020 |
Diagnostic utility of interferon gamma-induced protein 10 kDa in spontaneous bacterial peritonitis: single-center study A Abdel-Razik, N Mousa, S Elbaz, M Eissa, R Elhelaly, W Eldars European journal of gastroenterology & hepatology 27 (9), 1087-1093, 2015 | 26 | 2015 |
Cryptosporidiosis in patients with diarrhea and chronic liver diseases N Mousa, A Abdel-Razik, H El-Nahas, A El-Shazly, M Abdelaziz, M Nabih, ... The Journal of Infection in Developing Countries 8 (12), 1584-1590, 2014 | 19 | 2014 |
Is combination therapy for chronic hepatitis C toxic for cardiac function? R Almawardy, W Elhammady, N Mousa, S Abotaleb Hepatitis Monthly 12 (8), 2012 | 19 | 2012 |
Mansoura simple scoring system for prediction of spontaneous bacterial peritonitis: lesson learnt A Abdel-Razik, N Mousa, M Abdel-Aziz, W Elsherbiny, S Zakaria, ... European Journal of Gastroenterology & Hepatology 31 (8), 1017-1024, 2019 | 17 | 2019 |
Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes? N Mousa, T Besheer, Y Gad, A Elbendary, T Mokbel, A Abdel-Aziz Journal of ocular pharmacology and therapeutics 29 (3), 345-348, 2013 | 17 | 2013 |